{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:39:11Z","timestamp":1787002751847,"version":"build-2736575974"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T00:00:00Z","timestamp":1774656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009053","name":"DBT India Alliance","doi-asserted-by":"publisher","award":["IA\/CPHI\/18\/1\/503927"],"award-info":[{"award-number":["IA\/CPHI\/18\/1\/503927"]}],"id":[{"id":"10.13039\/501100009053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009053","name":"DBT India Alliance","doi-asserted-by":"publisher","award":["IA\/CPHI\/18\/1\/503927"],"award-info":[{"award-number":["IA\/CPHI\/18\/1\/503927"]}],"id":[{"id":"10.13039\/501100009053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009053","name":"DBT India Alliance","doi-asserted-by":"publisher","award":["IA\/CPHI\/18\/1\/503927"],"award-info":[{"award-number":["IA\/CPHI\/18\/1\/503927"]}],"id":[{"id":"10.13039\/501100009053","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Identifying biomarkers of epithelial\u2012mesenchymal transition (EMT) and metastasis play a decisive role in the prognosis and clinical management of Oral cancer (OC). Homeobox A9 (HOXA9), an imperative regulator of embryogenesis and endothelial cell proliferation, is aberrantly expressed in several malignancies, including OC. To date, HOXA9-mediated molecular mechanisms and their functional roles in EMT and OC metastasis remain poorly understood. In this study, we observed significant upregulation of HOXA9 in OC samples with lymph node-positive stage and higher histological grade. Notably, we demonstrated that retroviral-mediated knockdown of HOXA9 impairs proliferation, migration, and invasion while promoting apoptosis and cell cycle arrest. A substantial reduction in tumor volume and diminished lung metastasis was observed in nude mice receiving HOXA9-knockdown cells. Transcriptomic analysis of HOXA9-depleted cells revealed the downregulation of multiple pathways, with the most significant being \u201cpathways in cancer\u201d. We further demonstrated that HOXA9 transcriptionally activates\n                    <jats:italic>VIM<\/jats:italic>\n                    to promote EMT and it also facilitates \u03b2-catenin nuclear translocation, which subsequently activates downstream target genes driving Wnt\/\u03b2-catenin cascade. Our study also unveils HOXA9-driven molecular interplay in which HOXA9-dependent transcriptional activation of\n                    <jats:italic>VIM<\/jats:italic>\n                    triggers Wnt\/\u03b2-catenin cascade in OC. Furthermore, we demonstrated that hypomethylated CpGs at\n                    <jats:italic>HOXA9<\/jats:italic>\n                    promoter (spanning \u22124201bp to \u22123574bp upstream of TSS) in stage III\/IV tumors showed a significant inverse correlation between hypomethylation and gene upregulation. Consistently, analysis of the same distal promoter region revealed the enrichment of activating histone modifications, further supporting its transcriptional permissive state. Collectively, our study uncovers a novel mechanism by which epigenetically altered\n                    <jats:italic>HOXA9<\/jats:italic>\n                    serves as a potential inducer of EMT through regulation of VIM\/Wnt-\u03b2-catenin\/EMT signaling axis. These findings signify HOXA9 as a promising biomarker in OC and targeting HOXA9 could be an effective strategy to improve clinical outcome of patients diagnosed with advanced stages.\n                  <\/jats:p>","DOI":"10.1038\/s41419-026-08664-7","type":"journal-article","created":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T14:46:41Z","timestamp":1774709201000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["HOXA9 orchestrates EMT and metastasis in oral cancer via transcriptional activation of vimentin and \u03b2-catenin signaling"],"prefix":"10.1038","volume":"17","author":[{"given":"U. Sangeetha","family":"Shenoy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7934-0643","authenticated-orcid":false,"given":"Divya","family":"Adiga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhanraj Salur","family":"Basavarajappa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveena A. N.","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adarsh","family":"Kudva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9121-6816","authenticated-orcid":false,"given":"Ajaikumar B.","family":"Kunnumakkara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith D.","family":"Hunter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4158-3893","authenticated-orcid":false,"given":"Shama Prasada","family":"Kabekkodu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0088-4777","authenticated-orcid":false,"given":"Raghu","family":"Radhakrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,28]]},"reference":[{"key":"8664_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"8664_CR2","volume":"15","author":"S Borkar","year":"2023","unstructured":"Borkar S, Reche A, Paul P, Deshpande A, Deshpande M. Noninvasive technique for the screening and diagnosis of oral squamous cell carcinoma. Cureus. 2023;15:e46300.","journal-title":"Cureus"},{"key":"8664_CR3","volume":"12","author":"KSR Padam","year":"2022","unstructured":"Padam KSR, Morgan R, Hunter K, Chakrabarty S, Kumar NAN, Radhakrishnan R. Identification of HOX signatures contributing to oral cancer phenotype. Sci Rep. 2022;12:10123.","journal-title":"Sci Rep"},{"key":"8664_CR4","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.3892\/ijo.2011.1321","volume":"40","author":"CO Rodini","year":"2012","unstructured":"Rodini CO, Xavier FC, Paiva KB, De Souza Setubal Destro MF, Moyses RA, Michaluarte P, et al. Homeobox gene expression profile indicates HOXA5 as a candidate prognostic marker in oral squamous cell carcinoma. Int J Oncol. 2012;40:1180\u20138.","journal-title":"Int J Oncol"},{"key":"8664_CR5","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1590\/S1678-77572011000200008","volume":"19","author":"R Tucci","year":"2011","unstructured":"Tucci R, Campos MS, Matizonkas-Antonio LF, Durazzo M, Pinto Junior Ddos S, Nunes FD. HOXB5 expression in oral squamous cell carcinoma. J Appl Oral Sci. 2011;19:125\u20139.","journal-title":"J Appl Oral Sci"},{"key":"8664_CR6","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/jop.12388","volume":"45","author":"C Platais","year":"2016","unstructured":"Platais C, Hakami F, Darda L, Lambert DW, Morgan R, Hunter KD. The role of HOX genes in head and neck squamous cell carcinoma. J Oral Pathol Med. 2016;45:239\u201347.","journal-title":"J Oral Pathol Med"},{"key":"8664_CR7","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/35047605","volume":"2","author":"DE Ferrier","year":"2001","unstructured":"Ferrier DE, Holland PW. Ancient origin of the Hox gene cluster. Nat Rev Genet. 2001;2:33\u20138.","journal-title":"Nat Rev Genet"},{"key":"8664_CR8","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/wdev.78","volume":"2","author":"PW Holland","year":"2013","unstructured":"Holland PW. Evolution of homeobox genes. Wiley Interdiscip Rev Dev Biol. 2013;2:31\u201345.","journal-title":"Wiley Interdiscip Rev Dev Biol"},{"key":"8664_CR9","doi-asserted-by":"crossref","first-page":"20120367","DOI":"10.1098\/rstb.2012.0367","volume":"368","author":"T Montavon","year":"2013","unstructured":"Montavon T, Duboule D. Chromatin organization and global regulation of Hox gene clusters. Philos Trans R Soc Lond B Biol Sci. 2013;368:20120367.","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"8664_CR10","doi-asserted-by":"crossref","unstructured":"Ozernyuk N, Schepetov D. HOX-gene cluster organization and genome duplications in fishes and mammals: transcript variant distribution along the anterior-posterior axis. Int J Mol Sci. 2022;23:9990.","DOI":"10.3390\/ijms23179990"},{"key":"8664_CR11","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1038\/onc.2015.174","volume":"35","author":"CT Collins","year":"2016","unstructured":"Collins CT, Hess JL. Role of HOXA9 in leukemia: dysregulation, cofactors and essential targets. Oncogene. 2016;35:1090\u20138.","journal-title":"Oncogene"},{"key":"8664_CR12","doi-asserted-by":"crossref","first-page":"4347","DOI":"10.21037\/tcr-21-765","volume":"10","author":"H Cai","year":"2021","unstructured":"Cai H, Ke ZB, Dong RN, Chen H, Lin F, Zheng WC, et al. The prognostic value of homeobox A9 (HOXA9) methylation in solid tumors: a systematic review and meta-analysis. Transl Cancer Res. 2021;10:4347\u201354.","journal-title":"Transl Cancer Res"},{"key":"8664_CR13","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1002\/dvdy.21286","volume":"236","author":"DM Wellik","year":"2007","unstructured":"Wellik DM. Hox patterning of the vertebrate axial skeleton. Dev Dyn. 2007;236:2454\u201363.","journal-title":"Dev Dyn"},{"key":"8664_CR14","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1242\/dev.122.2.461","volume":"122","author":"C Fromental-Ramain","year":"1996","unstructured":"Fromental-Ramain C, Warot X, Lakkaraju S, Favier B, Haack H, Birling C, et al. Specific and redundant functions of the paralogous Hoxa-9 and Hoxd-9 genes in forelimb and axial skeleton patterning. Development. 1996;122:461\u201372.","journal-title":"Development"},{"key":"8664_CR15","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1093\/humrep\/deu004","volume":"29","author":"B Xu","year":"2014","unstructured":"Xu B, Geerts D, Bu Z, Ai J, Jin L, Li Y, et al. Regulation of endometrial receptivity by the highly expressed HOXA9, HOXA11 and HOXD10 HOX-class homeobox genes. Hum Reprod. 2014;29:781\u201390.","journal-title":"Hum Reprod"},{"key":"8664_CR16","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1371\/journal.pone.0000047","volume":"1","author":"J Yan","year":"2006","unstructured":"Yan J, Chen YX, Desmond A, Silva A, Yang Y, Wang H, et al. Cdx4 and menin co-regulate Hoxa9 expression in hematopoietic cells. PLoS ONE. 2006;1:e47.","journal-title":"PLoS ONE"},{"key":"8664_CR17","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1074\/jbc.274.3.1415","volume":"274","author":"CV Patel","year":"1999","unstructured":"Patel CV, Sharangpani R, Bandyopadhyay S, DiCorleto PE. Endothelial cells express a novel, tumor necrosis factor-alpha-regulated variant of HOXA9. J Biol Chem. 1999;274:1415\u201322.","journal-title":"J Biol Chem"},{"key":"8664_CR18","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.ydbio.2010.03.006","volume":"341","author":"N Di-Poi","year":"2010","unstructured":"Di-Poi N, Koch U, Radtke F, Duboule D. Additive and global functions of HoxA cluster genes in mesoderm derivatives. Dev Biol. 2010;341:488\u201398.","journal-title":"Dev Biol"},{"key":"8664_CR19","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12861-015-0078-5","volume":"15","author":"AM Raines","year":"2015","unstructured":"Raines AM, Magella B, Adam M, Potter SS. Key pathways regulated by HoxA9,10,11\/HoxD9,10,11 during limb development. BMC Dev Biol. 2015;15:28.","journal-title":"BMC Dev Biol"},{"key":"8664_CR20","doi-asserted-by":"crossref","DOI":"10.1186\/s12935-022-02767-9","volume":"22","author":"L Tang","year":"2022","unstructured":"Tang L, Peng L, Tan C, Liu H, Chen P, Wang H. Role of HOXA9 in solid tumors: mechanistic insights and therapeutic potential. Cancer Cell Int. 2022;22:349.","journal-title":"Cancer Cell Int"},{"key":"8664_CR21","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.7314\/APJCP.2016.17.3.1037","volume":"17","author":"L Alvarado-Ruiz","year":"2016","unstructured":"Alvarado-Ruiz L, Martinez-Silva MG, Torres-Reyes LA, Pina-Sanchez P, Ortiz-Lazareno P, Bravo-Cuellar A, et al. HOXA9 is underexpressed in cervical cancer cells and its restoration decreases proliferation, migration and expression of epithelial-to-mesenchymal transition genes. Asian Pac J Cancer Prev. 2016;17:1037\u201347.","journal-title":"Asian Pac J Cancer Prev"},{"key":"8664_CR22","doi-asserted-by":"crossref","first-page":"9920","DOI":"10.1073\/pnas.1305172110","volume":"110","author":"M Sun","year":"2013","unstructured":"Sun M, Song CX, Huang H, Frankenberger CA, Sankarasharma D, Gomes S, et al. HMGA2\/TET1\/HOXA9 signaling pathway regulates breast cancer growth and metastasis. Proc Natl Acad Sci USA. 2013;110:9920\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8664_CR23","doi-asserted-by":"crossref","first-page":"63935","DOI":"10.18632\/oncotarget.19212","volume":"8","author":"X Wang","year":"2017","unstructured":"Wang X, Bu J, Liu X, Wang W, Mai W, Lv B, et al. miR-133b suppresses metastasis by targeting HOXA9 in human colorectal cancer. Oncotarget. 2017;8:63935\u201348.","journal-title":"Oncotarget"},{"key":"8664_CR24","doi-asserted-by":"crossref","first-page":"15740","DOI":"10.18632\/oncotarget.24597","volume":"9","author":"Xavier-Magalhaes","year":"2018","unstructured":"Xavier-Magalhaes, Goncalves A, Fogli CS, Lourenco T A, Pojo M, Pereira B, et al. The long non-coding RNA HOTAIR is transcriptionally activated by HOXA9 and is an independent prognostic marker in patients with malignant glioma. Oncotarget. 2018;9:15740\u201356.","journal-title":"Oncotarget"},{"key":"8664_CR25","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1002\/1878-0261.12633","volume":"14","author":"CS Goncalves","year":"2020","unstructured":"Goncalves CS, Xavier-Magalhaes A, Martins EP, Pinto AA, Pires MM, Pinheiro C, et al. A novel molecular link between HOXA9 and WNT6 in glioblastoma identifies a subgroup of patients with particular poor prognosis. Mol Oncol. 2020;14:1224\u201341.","journal-title":"Mol Oncol"},{"key":"8664_CR26","volume":"9","author":"L Zhou","year":"2018","unstructured":"Zhou L, Wang Y, Zhou M, Zhang Y, Wang P, Li X, et al. HOXA9 inhibits HIF-1alpha-mediated glycolysis through interacting with CRIP2 to repress cutaneous squamous cell carcinoma development. Nat Commun. 2018;9:1480.","journal-title":"Nat Commun"},{"key":"8664_CR27","doi-asserted-by":"crossref","unstructured":"Han S, Li X, Liang X, Zhou L. HOXA9 transcriptionally promotes apoptosis and represses autophagy by targeting NF-kappaB in cutaneous squamous cell carcinoma. Cells. 2019;8:1360.","DOI":"10.3390\/cells8111360"},{"key":"8664_CR28","first-page":"1122","volume":"41","author":"Z Wang","year":"2019","unstructured":"Wang Z, Yu C, Wang H. HOXA5 inhibits the proliferation and induces the apoptosis of cervical cancer cells via regulation of protein kinase B and p27. Oncol Rep. 2019;41:1122\u201330.","journal-title":"Oncol Rep"},{"key":"8664_CR29","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1093\/carcin\/bgr222","volume":"32","author":"E Kendziorra","year":"2011","unstructured":"Kendziorra E, Ahlborn K, Spitzner M, Rave-Frank M, Emons G, Gaedcke J, et al. Silencing of the Wnt transcription factor TCF4 sensitizes colorectal cancer cells to (chemo-) radiotherapy. Carcinogenesis. 2011;32:1824\u201331.","journal-title":"Carcinogenesis"},{"key":"8664_CR30","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.2217\/bmm-2021-0144","volume":"15","author":"L Faaborg","year":"2021","unstructured":"Faaborg L, Jakobsen A, Waldstrom M, Petersen CB, Andersen RF, Steffensen KD. HOXA9-methylated DNA as a diagnostic biomarker of ovarian malignancy. Biomark Med. 2021;15:1309\u201317.","journal-title":"Biomark Med"},{"key":"8664_CR31","volume":"33","author":"C Zhou","year":"2019","unstructured":"Zhou C, Li J, Li Q, Liu H, Ye D, Wu Z, et al. The clinical significance of HOXA9 promoter hypermethylation in head and neck squamous cell carcinoma. J Clin Lab Anal. 2019;33:e22873.","journal-title":"J Clin Lab Anal"},{"key":"8664_CR32","volume":"9","author":"SM Park","year":"2017","unstructured":"Park SM, Choi EY, Bae M, Choi JK, Kim YJ. A long-range interactive DNA methylation marker panel for the promoters of HOXA9 and HOXA10 predicts survival in breast cancer patients. Clin Epigenetics. 2017;9:73.","journal-title":"Clin Epigenetics"},{"key":"8664_CR33","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1186\/s12957-021-02363-7","volume":"19","author":"Q Xu","year":"2021","unstructured":"Xu Q, Zhang Q, Dong M, Yu Y. MicroRNA-638 inhibits the progression of breast cancer through targeting HOXA9 and suppressing Wnt\/beta-cadherin pathway. World J Surg Oncol. 2021;19:247.","journal-title":"World J Surg Oncol"},{"key":"8664_CR34","doi-asserted-by":"crossref","first-page":"8905","DOI":"10.2147\/OTT.S227920","volume":"12","author":"C Xu","year":"2019","unstructured":"Xu C, Li B, Zhao S, Jin B, Jia R, Ge J, et al. MicroRNA-186-5p inhibits proliferation and metastasis of esophageal cancer by mediating HOXA9. Onco Targets Ther. 2019;12:8905\u201314.","journal-title":"Onco Targets Ther"},{"key":"8664_CR35","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.omto.2021.03.009","volume":"21","author":"SM Wang","year":"2021","unstructured":"Wang SM, Pang J, Zhang KJ, Zhou ZY, Chen FY. lncRNA MIR503HG inhibits cell proliferation and promotes apoptosis in TNBC cells via the miR-224-5p\/HOXA9 axis. Mol Ther Oncolytics. 2021;21:62\u201373.","journal-title":"Mol Ther Oncolytics"},{"key":"8664_CR36","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.omtn.2019.12.045","volume":"20","author":"Q Sun","year":"2020","unstructured":"Sun Q, Zhang SY, Zhao JF, Han XG, Wang HB, Sun ML. HIF-1alpha or HOTTIP\/CTCF promotes head and neck squamous cell carcinoma progression and drug resistance by targeting HOXA9. Mol Ther Nucleic Acids. 2020;20:164\u201375.","journal-title":"Mol Ther Nucleic Acids"},{"key":"8664_CR37","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2407-14-353","volume":"14","author":"K Uchida","year":"2014","unstructured":"Uchida K, Veeramachaneni R, Huey B, Bhattacharya A, Schmidt BL, Albertson DG. Investigation of HOXA9 promoter methylation as a biomarker to distinguish oral cancer patients at low risk of neck metastasis. BMC Cancer. 2014;14:353.","journal-title":"BMC Cancer"},{"key":"8664_CR38","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1158\/1940-6207.CAPR-11-0006","volume":"4","author":"R Guerrero-Preston","year":"2011","unstructured":"Guerrero-Preston R, Soudry E, Acero J, Orera M, Moreno-Lopez L, Macia-Colon G, et al. NID2 and HOXA9 promoter hypermethylation as biomarkers for prevention and early detection in oral cavity squamous cell carcinoma tissues and saliva. Cancer Prev Res. 2011;4:1061\u201372.","journal-title":"Cancer Prev Res"},{"key":"8664_CR39","volume":"10","author":"L Xiong","year":"2019","unstructured":"Xiong L, Wu F, Wu Q, Xu L, Cheung OK, Kang W, et al. Aberrant enhancer hypomethylation contributes to hepatic carcinogenesis through global transcriptional reprogramming. Nat Commun. 2019;10:335.","journal-title":"Nat Commun"},{"key":"8664_CR40","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-52437-1","volume":"14","author":"A Gehring","year":"2024","unstructured":"Gehring A, Huebner K, Rani H, Erlenbach-Wuensch K, Merkel S, Mahadevan V, et al. DNA demethylation and tri-methylation of H3K4 at the TACSTD2 promoter are complementary players for TROP2 regulation in colorectal cancer cells. Sci Rep. 2024;14:2683.","journal-title":"Sci Rep"},{"key":"8664_CR41","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1158\/0008-5472.CAN-16-2797","volume":"77","author":"R Malek","year":"2017","unstructured":"Malek R, Gajula RP, Williams RD, Nghiem B, Simons BW, Nugent K, et al. TWIST1-WDR5-hottip regulates Hoxa9 chromatin to facilitate prostate cancer metastasis. Cancer Res. 2017;77:3181\u201393.","journal-title":"Cancer Res"},{"key":"8664_CR42","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.bbrc.2007.11.151","volume":"367","author":"F Vesuna","year":"2008","unstructured":"Vesuna F, van Diest P, Chen JH, Raman V. Twist is a transcriptional repressor of E-cadherin gene expression in breast cancer. Biochem Biophys Res Commun. 2008;367:235\u201341.","journal-title":"Biochem Biophys Res Commun"},{"key":"8664_CR43","volume":"2014","author":"TS Wong","year":"2014","unstructured":"Wong TS, Gao W, Chan JY. Transcription regulation of E-cadherin by zinc finger E-box binding homeobox proteins in solid tumors. Biomed Res Int. 2014;2014:921564.","journal-title":"Biomed Res Int"},{"key":"8664_CR44","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1172\/JCI39534","volume":"120","author":"PM Gilbert","year":"2010","unstructured":"Gilbert PM, Mouw JK, Unger MA, Lakins JN, Gbegnon MK, Clemmer VB, et al. HOXA9 regulates BRCA1 expression to modulate human breast tumor phenotype. J Clin Investig. 2010;120:1535\u201350.","journal-title":"J Clin Investig"},{"key":"8664_CR45","doi-asserted-by":"crossref","first-page":"137","DOI":"10.21873\/cgp.20026","volume":"14","author":"GO Chong","year":"2017","unstructured":"Chong GO, Jeon HS, Han HS, Son JW, Lee YH, Hong DG, et al. Overexpression of microRNA-196b accelerates invasiveness of cancer cells in recurrent epithelial ovarian cancer through regulation of homeobox A9. Cancer Genomics Proteomics. 2017;14:137\u201341.","journal-title":"Cancer Genomics Proteomics"},{"key":"8664_CR46","doi-asserted-by":"crossref","first-page":"7141","DOI":"10.1158\/1078-0432.CCR-17-1222","volume":"23","author":"A Ooki","year":"2017","unstructured":"Ooki A, Maleki Z, Tsay JJ, Goparaju C, Brait M, Turaga N, et al. A panel of novel detection and prognostic methylated DNA markers in primary non-small cell lung cancer and serum dnA. Clin Cancer Res. 2017;23:7141\u201352.","journal-title":"Clin Cancer Res"},{"key":"8664_CR47","volume":"13","author":"L Gao","year":"2020","unstructured":"Gao L, Yan SB, Yang J, Kong JL, Shi K, Ma FC, et al. MiR-182-5p and its target HOXA9 in non-small cell lung cancer: a clinical and in-silico exploration with the combination of RT-qPCR, miRNA-seq and miRNA-chip. BMC Med Genomics. 2020;13:3.","journal-title":"BMC Med Genomics"},{"key":"8664_CR48","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.lungcan.2018.05.021","volume":"122","author":"D Lissa","year":"2018","unstructured":"Lissa D, Ishigame T, Noro R, Tucker MJ, Bliskovsky V, Shema S, et al. HOXA9 methylation and blood vessel invasion in FFPE tissues for prognostic stratification of stage I lung adenocarcinoma patients. Lung Cancer. 2018;122:151\u20139.","journal-title":"Lung Cancer"},{"key":"8664_CR49","doi-asserted-by":"crossref","first-page":"8722","DOI":"10.12659\/MSM.917099","volume":"25","author":"Z Xia","year":"2019","unstructured":"Xia Z, Yang C, Yang X, Wu S, Feng Z, Qu L, et al. miR-652 promotes proliferation and migration of uveal melanoma cells by targeting HOXA9. Med Sci Monit. 2019;25:8722\u201332.","journal-title":"Med Sci Monit"},{"key":"8664_CR50","first-page":"8582","volume":"22","author":"ZF Zhang","year":"2018","unstructured":"Zhang ZF, Li GR, Cao CN, Xu Q, Wang GD, Jiang XF. MicroRNA-1294 targets HOXA9 and has a tumor suppressive role in osteosarcoma. Eur Rev Med Pharmacol Sci. 2018;22:8582\u20138.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"8664_CR51","first-page":"5883","volume":"14","author":"YY Ma","year":"2017","unstructured":"Ma YY, Zhang Y, Mou XZ, Liu ZC, Ru GQ, Li E. High level of homeobox A9 and PBX homeobox 3 expression in gastric cancer correlates with poor prognosis. Oncol Lett. 2017;14:5883\u20139.","journal-title":"Oncol Lett"},{"key":"8664_CR52","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.canlet.2017.09.019","volume":"410","author":"Z Fu","year":"2017","unstructured":"Fu Z, Chen C, Zhou Q, Wang Y, Zhao Y, Zhao X, et al. LncRNA HOTTIP modulates cancer stem cell properties in human pancreatic cancer by regulating HOXA9. Cancer Lett. 2017;410:68\u201381.","journal-title":"Cancer Lett"},{"key":"8664_CR53","first-page":"2756","volume":"15","author":"Y Watanabe","year":"2018","unstructured":"Watanabe Y, Saito M, Saito K, Matsumoto Y, Kanke Y, Onozawa H, et al. Upregulated HOXA9 expression is associated with lymph node metastasis in colorectal cancer. Oncol Lett. 2018;15:2756\u201362.","journal-title":"Oncol Lett"},{"key":"8664_CR54","doi-asserted-by":"crossref","unstructured":"Osmond B, Facey COB, Zhang C, Boman BM. HOXA9 overexpression contributes to stem cell overpopulation that drives development and growth of colorectal cancer. Int J Mol Sci. 2022;23.","DOI":"10.3390\/ijms23126799"},{"key":"8664_CR55","doi-asserted-by":"crossref","first-page":"4147","DOI":"10.2147\/CMAR.S305814","volume":"13","author":"T Liu","year":"2021","unstructured":"Liu T, Ji C, Sun Y, Bai W. HOXA9 expression is associated with advanced tumour stage and prognosis in nasopharyngeal carcinoma. Cancer Manag Res. 2021;13:4147\u201354.","journal-title":"Cancer Manag Res"},{"key":"8664_CR56","doi-asserted-by":"crossref","first-page":"467","DOI":"10.3727\/096504013X13685487925257","volume":"20","author":"X Sun","year":"2013","unstructured":"Sun X, Liu B, Ji W, Ma X, Wang X, Gu H. The role of HOXA9 in human laryngeal squamous cell carcinoma. Oncol Res. 2013;20:467\u201372.","journal-title":"Oncol Res"},{"key":"8664_CR57","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/onc.2016.304","volume":"36","author":"T Zhan","year":"2017","unstructured":"Zhan T, Rindtorff N, Boutros M. Wnt signaling in cancer. Oncogene. 2017;36:1461\u201373.","journal-title":"Oncogene"},{"key":"8664_CR58","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00018-023-05099-7","volume":"81","author":"W Xue","year":"2024","unstructured":"Xue W, Yang L, Chen C, Ashrafizadeh M, Tian Y, Sun R. Wnt\/beta-catenin-driven EMT regulation in human cancers. Cell Mol Life Sci. 2024;81:79.","journal-title":"Cell Mol Life Sci"},{"key":"8664_CR59","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1039\/C6MB00786D","volume":"13","author":"RR Padala","year":"2017","unstructured":"Padala RR, Karnawat R, Viswanathan SB, Thakkar AV, Das AB. Cancerous perturbations within the ERK, PI3K\/Akt, and Wnt\/beta-catenin signaling network constitutively activate inter-pathway positive feedback loops. Mol Biosyst. 2017;13:830\u201340.","journal-title":"Mol Biosyst"},{"key":"8664_CR60","volume":"24","author":"F Cai","year":"2024","unstructured":"Cai F, Li J, Zhang Y, Huang S, Liu W, Zhuo W, et al. Interaction between Wnt\/beta-catenin signaling pathway and EMT pathway mediates the mechanism of sunitinib resistance in renal cell carcinoma. BMC Cancer. 2024;24:175.","journal-title":"BMC Cancer"},{"key":"8664_CR61","doi-asserted-by":"crossref","first-page":"3730","DOI":"10.1111\/jcmm.13282","volume":"21","author":"K Wang","year":"2017","unstructured":"Wang K, Jin J, Ma T, Zhai H. MiR-139-5p inhibits the tumorigenesis and progression of oral squamous carcinoma cells by targeting HOXA9. J Cell Mol Med. 2017;21:3730\u201340.","journal-title":"J Cell Mol Med"},{"key":"8664_CR62","volume":"266","author":"B Mei","year":"2025","unstructured":"Mei B, Zeng Z, Xia Q, Liu M, Zhang Y. The role of the circ_DOCK1-miR-1297-HOXA9 regulatory network in the development of oral squamous cell carcinoma. Pathol Res Pract. 2025;266:155752.","journal-title":"Pathol Res Pract"},{"key":"8664_CR63","doi-asserted-by":"crossref","first-page":"293","DOI":"10.2217\/epi-2023-0053","volume":"15","author":"X Wang","year":"2023","unstructured":"Wang X, Shen J, Wang L, Deng L, Bo H, Luo Y, et al. DNA hypomethylation and upregulated LINC00518 acts as a promoter and biomarker in head and neck squamous cell carcinoma. Epigenomics. 2023;15:293\u2013306.","journal-title":"Epigenomics"},{"key":"8664_CR64","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/s12033-023-00727-w","volume":"66","author":"X Hou","year":"2024","unstructured":"Hou X, Liao Q, Wu Y, Wang L, Zhao J, Liao X. Hypomethylation-mediated upregulation of NFE2L3 promotes malignant phenotypes of clear cell renal cell carcinoma cells. Mol Biotechnol. 2024;66:198\u2013207.","journal-title":"Mol Biotechnol"},{"key":"8664_CR65","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1128\/MCB.20.4.1436-1447.2000","volume":"20","author":"MA Dickson","year":"2000","unstructured":"Dickson MA, Hahn WC, Ino Y, Ronfard V, Wu JY, Weinberg RA, et al. Human keratinocytes that express hTERT and also bypass a p16(INK4a)-enforced mechanism that limits life span become immortal yet retain normal growth and differentiation characteristics. Mol Cell Biol. 2000;20:1436\u201347.","journal-title":"Mol Cell Biol"},{"key":"8664_CR66","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25:402\u20138.","journal-title":"Methods"},{"key":"8664_CR67","doi-asserted-by":"crossref","first-page":"D1115","DOI":"10.1093\/nar\/gkab959","volume":"50","author":"BT Lee","year":"2022","unstructured":"Lee BT, Barber GP, Benet-Pages A, Casper J, Clawson H, Diekhans M, et al. The UCSC Genome Browser database: 2022 update. Nucleic Acids Res. 2022;50:D1115\u2013D22.","journal-title":"Nucleic Acids Res"},{"key":"8664_CR68","doi-asserted-by":"crossref","first-page":"D92","DOI":"10.1093\/nar\/gku1111","volume":"43","author":"R Dreos","year":"2015","unstructured":"Dreos R, Ambrosini G, Perier RC, Bucher P. The eukaryotic promoter database: expansion of EPDnew and new promoter analysis tools. Nucleic Acids Res. 2015;43:D92\u20136.","journal-title":"Nucleic Acids Res"},{"key":"8664_CR69","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/bioinformatics\/18.2.333","volume":"18","author":"X Messeguer","year":"2002","unstructured":"Messeguer X, Escudero R, Farre D, Nunez O, Martinez J, Alba MM. PROMO: detection of known transcription regulatory elements using species-tailored searches. Bioinformatics. 2002;18:333\u20134.","journal-title":"Bioinformatics"},{"key":"8664_CR70","first-page":"2","volume":"011","author":"R Andersson","year":"2010","unstructured":"Andersson R, Gebhard C, Miguel-Escalada I, Hoof I, Bornholdt J, Boyd M, et al. FastQC: A quality control tool for high throughput sequence data. Version. 2010;011:2.","journal-title":"Version"},{"key":"8664_CR71","doi-asserted-by":"crossref","first-page":"D729","DOI":"10.1093\/nar\/gky1094","volume":"47","author":"R Zheng","year":"2019","unstructured":"Zheng R, Wan C, Mei S, Qin Q, Wu Q, Sun H, et al. Cistrome data browser: expanded datasets and new tools for gene regulatory analysis. Nucleic Acids Res. 2019;47:D729\u2013D35.","journal-title":"Nucleic Acids Res"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08664-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08664-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08664-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T10:08:43Z","timestamp":1778148523000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08664-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,28]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8664"],"URL":"https:\/\/doi.org\/10.1038\/s41419-026-08664-7","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,28]]},"assertion":[{"value":"3 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Informed consent was obtained from all the individual participants included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for participation"}},{"value":"All the authors have read and approved the final manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"428"}}